D-0799-2016 Class III Terminated

Recalled by Genzyme Corporation — Cambridge, MA

FDA drug recall D-0799-2016 was initiated by Genzyme Corporation on Dec 8, 2015 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is terminated (terminated Aug 1, 2016). Affected quantity: 24 vials.

Recall details

Product Type
Drugs
Report Date
Apr 6, 2016
Initiation Date
Dec 8, 2015
Termination Date
Aug 1, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24 vials

Product description

Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by Genzyme Corportation, Cambridge, MA 02142, NDC 58468-0160-1

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Distribution pattern

TN

Code information

Lot # C5370C02; Exp. 02/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0799-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Genzyme Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0799-2016. Report a data issue: hello@regdatalab.com.